Drug Discovery

Study Reveals How Single Gene Mutations Shape Cancer Behavior
Research & Development Study Reveals How Single Gene Mutations Shape Cancer Behavior

The traditional classification of cancer based primarily on the organ where a tumor first appears is rapidly being superseded by a sophisticated genomic perspective that prioritizes the specific molecular drivers of the disease. Recent breakthroughs led by Dr. Derya Deniz Özdemir and an

How Do Cellular Highways Spread Huntington’s Disease?
Research & Development How Do Cellular Highways Spread Huntington’s Disease?

Huntington’s disease remains one of the most devastating neurological conditions known to modern medicine, characterized by a relentless decline in both motor control and cognitive function that eventually strips patients of their independence and identity. This genetic disorder stems from a

Can Korean Biotech Redefine Next-Gen Cancer Treatments?
Research & Development Can Korean Biotech Redefine Next-Gen Cancer Treatments?

The 2026 American Association for Cancer Research annual meeting in San Diego stands as a definitive proving ground where South Korean biotechnology firms must transition from theoretical promise to clinical validation. Unlike later-stage conferences such as ASCO or ESMO, the AACR provides a unique

Recursion Pharmaceuticals Accelerates Drug Discovery With AI
Research & Development Recursion Pharmaceuticals Accelerates Drug Discovery With AI

The complexity of biological systems often leaves pharmaceutical researchers grappling with a vast "dark matter" of untreatable conditions, where nearly 90% of human biology remains untouched by current therapeutic interventions. This systemic limitation has historically led to a high-risk and

Can Engineered CAR-T Cells Breach Solid Tumor Defenses?
Research & Development Can Engineered CAR-T Cells Breach Solid Tumor Defenses?

While Chimeric Antigen Receptor (CAR) T-cell therapy has successfully transformed the clinical outlook for patients with liquid cancers, its efficacy against solid tumors remains one of the most significant hurdles in modern oncology. Unlike the accessible environment of the bloodstream, where

Henlius Challenges Pfizer in PD-L1 Lung Cancer Drug Race
Research & Development Henlius Challenges Pfizer in PD-L1 Lung Cancer Drug Race

The pharmaceutical landscape is currently witnessing a high-stakes confrontation as Shanghai Henlius Biotech maneuvers to intercept Pfizer’s dominance in the next generation of lung cancer therapy. At the heart of this struggle is the development of antibody-drug conjugates (ADCs) targeting PD-L1,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later